Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

NCT05730283 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Ototoxicity, Drug-Induced

Interventions

DRUG: ORC-13661
DRUG: ORC-13661
DRUG: Placebo

Sponsor

Kevin Winthrop

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]